Botulinum Toxin Market Size Study, by Type, by Application and Regional Forecasts, 2022-2030

The Global Botulinum Toxin Market size is estimated to be USD 4.61 billion in 2019 and is predicted to reach USD 8.48 billion by 2030 with a CAGR of 7.1% from 2020-2030.

Botulinum toxin (BTX), also called as miracle poison, is a neurotoxin that is produced by the bacterium Clostridium botulinum. Botulinum toxin was initially used to treat dystonia, a neuromuscular disorder that produces involuntary muscle contractions or spasms. Currently, this neurotoxin is known for its paradoxical ability to remove wrinkles.

Over past few years, there has been a growing number of therapeutic applications for botulinum toxin, including treatment for migraines, leaky bladders, excessive sweating, and cardiac conditions. These increasing number of therapeutic applications propelled researchers to study and identify new versions of this protein. In January 2018, Canadian and American scientists discovered a new source of the botulinum neurotoxin, in a strain of animal gut bacteria known as Enterococcus faecium. According to the recent studies, as botulinum toxin is a powerful and versatile protein therapeutic, discovering more versions of this toxin in nature, can potentially expand and optimize its therapeutic applications, and thus can open new avenues in the market.

Access Full Description of this report at:-

https://www.nextmsc.com/report/botulinum-toxin-market

Top Companies: Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc., Lanzhou Institute of Biological Products Co. Ltd. Insys Therapeutics and Revance Therapeutics, Inc and others.

Market Dynamics and Trends:

Increasing aging population and rising awareness regarding botulinum toxin procedures in geriatric population, and growing demand for minimally invasive and non-invasive aesthetic and therapeutic procedures are the major factors driving the growth of botulinum toxin market. Additionally, increasing prevalence of spasticity and cervical dystonia and the number of cases of migraine is expected to drive the botulinum toxin market, globally. However, adverse effects such as allergic reactions, rash, neck pain, back pain, difficulty in swallowing, shortness of breath and nausea are hampering the adoption of neurotoxins in therapeutics as well as cosmetic application. Moreover, high cost of these procedures, and poor reimbursement coverage of the products are further expected to restrain the growth of the market.

Extensive research & development is the major focus of most of the players in this market. Companies such as Medytox and Ipsen concentrates on enhancing their research capacity on botulinum toxin products. In March 2018, Huons Global completed patient enrollment for phase 3 clinical studies of Hutox, its botulinum toxin used for forehead wrinkle treatment. Some pharmaceutical companies are also making efforts to launch topical botulinum toxin A. However, developing a topical product with an effective mechanism of action presents a large challenge for the companies. In addition to product development and launches, attention on increasing focus on enhancing international presence, robust marketing, and product reliability, also help the companies in gaining an upper hand over its competitors in the botulinum toxin market.

Request sample copy of this report at:-

https://www.nextmsc.com/Botulinum-Toxin-Market/request-sample

Market Segmentations and Scope of the Study:

The botulinum toxin market share is analysed on the basis of product, application, and geography. The product segment covers the market for botulinum toxin type A and botulinum toxin type B. By application the market is divided into aesthetic and therapeutics. The geographical segmentation covers North America, Europe, Asia Pacific, and Rest of the World.

Contact:
Phone Number: +1-217-650-7991
E-mail: info@nextmsc.com

About Next Move Strategy Consulting:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

For more insights, please visit, https://www.nextmsc.com

This release was published on openPR.